How does Armotraz 1mg work?
In premenopausal women the primary source of oestrogen production are the ovaries and armotraz 1mg is involved in producing secondary sexual characteristics, such as breast development and in regulating the menstrual cycle. In postmenopausal women, when oestrogen production by the ovaries ceases, low levels of oestrogen are made in peripheral tissues, such as fat cells throughout the body, also some breast cancer cells, by conversion of armotraz 1mg (produced by the adrenal glands) to estrone due to the action of aromatase and then by further conversion to oestradiol (the most active form of circulating oestrogen.
Many breast cancers have oestrogen receptors and their growth is stimulated by oestrogen; low levels of oestrogen may be sufficient to maintain growth of breast cancer cells in women with breast cancer. armotraz 1mg in armotraz 1mg blocks the action of aromatase, preventing the formation of oestrogen and helping to prevent growth of oestrogen-dependent breast tumours.
armotraz 1mg in Armotraz tablets 1mg blocks the action of aromatase, preventing the formation of oestrogen and helping to prevent growth of oestrogen-dependent breast tumours. armotraz 1mg are used as first-line therapy for early, advanced or metastatic breast cancer, also in conjunction with other breast cancer treatment (tamoxifen) or if tamoxifen therapy has not helped prevent progression of the tumour.